NIC Inc. (EGOV) formed double bottom with $15.94 target or 4.00% below today’s $16.60 share price. NIC Inc. (EGOV) has $1.10 billion valuation. The stock decreased 0.60% or $0.1 during the last trading session, reaching $16.6. About 486,553 shares traded. NIC Inc. (NASDAQ:EGOV) has risen 13.72% since December 31, 2016 and is uptrending. It has underperformed by 2.98% the S&P500.
Capital International Ltd increased Seattle Genetics Inc (SGEN) stake by 67.7% reported in 2017Q3 SEC filing. Capital International Ltd acquired 131,000 shares as Seattle Genetics Inc (SGEN)’s stock rose 1.68%. The Capital International Ltd holds 324,515 shares with $17.66M value, up from 193,515 last quarter. Seattle Genetics Inc now has $7.70 billion valuation. The stock decreased 2.80% or $1.54 during the last trading session, reaching $53.5. About 450,829 shares traded. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since December 31, 2016 and is uptrending. It has outperformed by 58.98% the S&P500.
Since August 7, 2017, it had 0 insider purchases, and 17 sales for $9.99 million activity. The insider DOBMEIER ERIC sold 25,000 shares worth $1.31M. $236,455 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) shares were sold by SIMPSON TODD E. Cline Darren S had sold 1,788 shares worth $85,635. $407,199 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) was sold by DRACHMAN JONATHAN G. SIEGALL CLAY B sold $1.22M worth of stock or 25,506 shares. HIMES VAUGHN B sold 10,000 shares worth $532,190.
Investors sentiment decreased to 0.78 in Q3 2017. Its down 0.52, from 1.3 in 2017Q2. It turned negative, as 51 investors sold SGEN shares while 74 reduced holdings. 29 funds opened positions while 69 raised stakes. 140.23 million shares or 2.00% more from 137.48 million shares in 2017Q2 were reported. 7,215 were reported by Metropolitan Life Ins Com. 125,000 were reported by Rock Springs Management Lp. 8,224 are held by Lpl Ltd Company. American Century holds 0% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN) for 9,816 shares. Stifel Finance owns 4,196 shares. 6,935 were accumulated by Keybank Natl Association Oh. Ecor1 Capital Ltd Liability Company holds 30,000 shares or 0.22% of its portfolio. Raymond James Fincl Advsr stated it has 4,654 shares or 0% of all its holdings. Meeder Asset Mgmt invested 0% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). Glg Ltd Company invested 0.02% in Seattle Genetics, Inc. (NASDAQ:SGEN). Ny State Common Retirement Fund holds 0.02% or 265,358 shares. Morgan Stanley invested in 0.01% or 407,910 shares. Pictet Asset Management Limited invested in 1.27 million shares or 0.2% of the stock. Mufg Americas Corp accumulated 100 shares or 0% of the stock. South Dakota Inv Council accumulated 0.06% or 49,900 shares.
Among 18 analysts covering Seattle Genetics (NASDAQ:SGEN), 7 have Buy rating, 0 Sell and 11 Hold. Therefore 39% are positive. Seattle Genetics had 56 analyst reports since July 31, 2015 according to SRatingsIntel. The company was maintained on Friday, October 27 by SunTrust. H.C. Wainwright maintained the shares of SGEN in report on Friday, October 27 with “Buy” rating. The rating was maintained by RBC Capital Markets with “Outperform” on Tuesday, December 6. As per Thursday, September 15, the company rating was upgraded by Goldman Sachs. The company was maintained on Friday, September 15 by Needham. The rating was maintained by Jefferies with “Buy” on Tuesday, September 12. On Wednesday, August 16 the stock rating was maintained by Cantor Fitzgerald with “Hold”. Cowen & Co maintained the shares of SGEN in report on Tuesday, June 6 with “Hold” rating. On Wednesday, July 27 the stock rating was maintained by Barclays Capital with “Overweight”. The stock has “Hold” rating by Oppenheimer on Tuesday, October 10.
Capital International Ltd decreased 01 stake by 766,000 shares to 4.50 million valued at $4.92M in 2017Q3. It also reduced Wynn Resorts Ltd (NASDAQ:WYNN) stake by 3,100 shares and now owns 115,000 shares. Royal Caribbean Cruises Ltd (NYSE:RCL) was reduced too.
Analysts await NIC Inc. (NASDAQ:EGOV) to report earnings on February, 7. They expect $0.16 EPS, down 20.00% or $0.04 from last year’s $0.2 per share. EGOV’s profit will be $10.60M for 25.94 P/E if the $0.16 EPS becomes a reality. After $0.21 actual EPS reported by NIC Inc. for the previous quarter, Wall Street now forecasts -23.81% negative EPS growth.
Among 7 analysts covering NIC (NASDAQ:EGOV), 1 have Buy rating, 1 Sell and 5 Hold. Therefore 14% are positive. NIC had 16 analyst reports since August 11, 2015 according to SRatingsIntel. The stock has “Overweight” rating by Stephens on Monday, August 17. The firm earned “Neutral” rating on Monday, December 19 by Sidoti. Maxim Group maintained NIC Inc. (NASDAQ:EGOV) rating on Friday, August 5. Maxim Group has “Hold” rating and $23 target. The stock has “Outperform” rating by Imperial Capital on Tuesday, August 11. The firm has “Hold” rating by Sidoti given on Friday, July 21. The firm has “Buy” rating by Imperial Capital given on Monday, July 17. As per Wednesday, February 15, the company rating was initiated by Loop Capital. The rating was downgraded by Avondale to “Market Perform” on Friday, February 5. Imperial Capital maintained NIC Inc. (NASDAQ:EGOV) rating on Wednesday, November 18. Imperial Capital has “In-Line” rating and $22 target. The firm has “In-Line” rating by Imperial Capital given on Friday, November 18.